These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 24022398)
1. Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases. Liu R; Liu J; Ji X; Liu Y Metab Brain Dis; 2013 Dec; 28(4):551-62. PubMed ID: 24022398 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment. Li J; Wang Y; Zhu Y; Oupický D J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358 [TBL] [Abstract][Full Text] [Related]
8. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Lee Y; El Andaloussi S; Wood MJ Hum Mol Genet; 2012 Oct; 21(R1):R125-34. PubMed ID: 22872698 [TBL] [Abstract][Full Text] [Related]
9. Exosome mediated delivery of functional nucleic acid nanoparticles (NANPs). Nordmeier S; Ke W; Afonin KA; Portnoy V Nanomedicine; 2020 Nov; 30():102285. PubMed ID: 32781137 [TBL] [Abstract][Full Text] [Related]
10. Exosomes as novel bio-carriers for gene and drug delivery. Jiang XC; Gao JQ Int J Pharm; 2017 Apr; 521(1-2):167-175. PubMed ID: 28216464 [TBL] [Abstract][Full Text] [Related]
11. Exosome as a Natural Gene Delivery Vector for Cancer Treatment. Pofali P; Mondal A; Londhe V Curr Cancer Drug Targets; 2020; 20(11):821-830. PubMed ID: 32972340 [TBL] [Abstract][Full Text] [Related]
12. Exosomes: Therapy delivery tools and biomarkers of diseases. Barile L; Vassalli G Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367 [TBL] [Abstract][Full Text] [Related]
13. Non-viral nucleic acid delivery: key challenges and future directions. Elsabahy M; Nazarali A; Foldvari M Curr Drug Deliv; 2011 May; 8(3):235-44. PubMed ID: 21291381 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. Zhang Y; Liu Q; Zhang X; Huang H; Tang S; Chai Y; Xu Z; Li M; Chen X; Liu J; Yang C J Nanobiotechnology; 2022 Jun; 20(1):279. PubMed ID: 35701788 [TBL] [Abstract][Full Text] [Related]
15. The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system. Jiang XC; Zhang T; Gao JQ Adv Drug Deliv Rev; 2022 Aug; 187():114324. PubMed ID: 35640803 [TBL] [Abstract][Full Text] [Related]
16. Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery. Soltani F; Parhiz H; Mokhtarzadeh A; Ramezani M Curr Pharm Des; 2015; 21(42):6214-35. PubMed ID: 26503143 [TBL] [Abstract][Full Text] [Related]
17. Characteristics and Roles of Exosomes in Cardiovascular Disease. Zhang Y; Hu YW; Zheng L; Wang Q DNA Cell Biol; 2017 Mar; 36(3):202-211. PubMed ID: 28112546 [TBL] [Abstract][Full Text] [Related]
18. Extracellular targeting of synthetic therapeutic nucleic acid formulations. Philipp A; Meyer M; Wagner E Curr Gene Ther; 2008 Oct; 8(5):324-34. PubMed ID: 18855630 [TBL] [Abstract][Full Text] [Related]
19. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications. Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956 [TBL] [Abstract][Full Text] [Related]
20. Exosome-based small RNA delivery: Progress and prospects. Lu M; Xing H; Xun Z; Yang T; Ding P; Cai C; Wang D; Zhao X Asian J Pharm Sci; 2018 Jan; 13(1):1-11. PubMed ID: 32104373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]